Skip to content

Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy (COLO-GENIUS)

Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy on Adenoma Detection Rate in Routine Practice: a Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04440865
Acronym
COLO-GENIUS
Enrollment
2100
Registered
2020-06-22
Start date
2021-02-01
Completion date
2022-04-20
Last updated
2022-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Colonic Adenoma, Colonic Neoplasms, Colonic Polyp, Colonoscopy

Brief summary

This controlled-randomized trial compares the artificial intelligence Genius® system assisted (Genius+) to standard (Genius-) colonoscopy. The aim of this study was to evaluate the impact of Genius® system on ADR in routine colonoscopy. The secondary aims will be the impact of Genius® system on polyp detection rate (PDR), serrated polyp detection rate (SPDR), advanced neoplasia detection rate (ANDR), mean number of polyps (MNP), polyp type and localization, and operator type (according to basal ADR).

Detailed description

Any patient seen by gastroenterologists working in the endoscopy unit and meeting the inclusion criteria may be recruited. The patient will be offered to participate in the study. The information form as well as the consent, will be given to the patient for a good understanding of the study and the investigator in charge of the patient gives all the additional explanations necessary for this good understanding (but of the study, the course, risks and benefits). A period of reflection will be left to the patient or his family to make a free decision whether or not to participate in the study. After the consent to participate will be signed by the gastroenterologist and the patient, the patient will be randomized. The use of the Genius® system will depend on the randomization that will be performed at the start of the colonoscopy. This randomization will be done in the computer examination room using the randomization software. The patient will therefore be randomized into 2 groups: Arm 1- Standard colonoscopy Arm 2- Colonoscopy assisted by Genius® system A comparison of the two groups standard colonoscopy vs colonoscopy assisted by Genius® system will be made as following: A-Main criterion: \- Adenoma detection rate (ADR) B-Secondary criteria: Polyps detection rate (PDR) Proximal serrated polyps detection rate (PSPDR) Neoplasia detection rate (NDR) Mean number of polyps (MNP) Mean number of adenomas (MNA) Factors associated with ADR

Interventions

OTHERGenius® System-assisted Colonoscopy

Genius® Intelligence System is used to assist Colonoscopy

OTHERStandard Colonoscopy

Standard Colonoscopy without Genius® Intelligence System is performed

Sponsors

Clinique Paris-Bercy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Arm 1- Standard colonoscopy Arm 2- Colonoscopy assisted by Genius® system

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient scheduled for total colonoscopic exploration, during the period study * Patient over or equal to 18 years * ASA 1, ASA 2, ASA 3 * No participation in another clinical study * Certificate of non opposition signed

Exclusion criteria

* Patient under 18 years old * ASA 4, ASA 5 * Pregnant woman * Patient with coagulation abnormalities preventing polypectomy: prothrombin level \<50%, Platelets \<50000 / mm3, effective anti-coagulation in progress, clopidogrel in progress. * Patient referred for resection of a known polyp * Inflammatory bowel disease * Known colonic stenosis * Diverticulitis less than 6 weeks old * Patient unable to give consent or protected by law * Opposition expressed for inclusion in the study

Design outcomes

Primary

MeasureTime frameDescription
Adenoma Detection Rate (ADR)1 daypercentage of colonoscopy with one or more adenoma of the colon

Secondary

MeasureTime frameDescription
Morbidity: bleeding rate (%)7 days after procedureBleeding rates (%)
Advanced Neoplasia Detection Rate (ANDR)1 daypercentage of colonoscopy with one or more advanced neoplasia of the colon
Proximal Serrated Polyp Detection Rate (PSPDR)1 daypercentage of colonoscopy with one or more serrated polyp of the colon
Morbidity: perforation rate (%)7 days after procedurePerforation rates (%)
The factors influencing the Adenoma Detection Rate (ADR)1 dayWithdrawal time (in seconds): time of exploration from the caecum to the anal verge
Time to reach caecum (sec)1 dayTime to reach caecum from the beginning of the procedure (in seconds)
Caecal intubation rate (%)1 dayCaecal intubation rate (complete colonoscopy)
Polyp Detection Rate (PDR)1 daypercentage of colonoscopy with one or more polyp of the colon

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026